We use cookies to ensure that we give you the best experience on our website. When you use our platform without an account you need to read and accept the Terms of Service, Data Policy and Disclaimer(s).
Cardinal Health stock remains a buy due to strong pharmaceutical business growth and increased shareholder returns, despite short-term OptumRx and …